Our Patented Formula

Backed by US Patents and University Research

The Patents
MaculaPM® is backed by US patents 11,969,401 and 9,173,862. The formulation benefited from research conducted at the University of Arizona and is licensed through Tech Launch Arizona.

Media gallery

The Innovation

Most eye supplements were designed around the same antioxidant formula developed in the 1990s. MaculaPM® goes further, reflecting what researchers at the University of Arizona now understand about how the eye actually works.
The formula takes a broader approach by incorporating L-DOPA—a potent regulator of eye health by signaling the GPR143 receptor—and melatonin, which supports circadian timing

A More Complete View

This combination reflects a more complete strategy for supporting healthy vision during aging. Together, these ingredients support not just the structure of the eye, but also how it functions and when it performs its most important daily processes.

MaculaPM® Nighttime Eye Support

$57.99

Science-based · Doctor-derived · University-researched
MaculaPM® — Nighttime eye support formulated around retinal signaling and circadian biology.

While you sleep, the eye performs its most important maintenance and renewal processes. MaculaPM® is a once-nightly formula built around this biology — combining L-DOPA, melatonin, and key macular nutrients selected for their roles in retinal signaling, nighttime circadian function, and macular support.†

Developed by researchers at the University of Arizona. Backed by US patents 11,969,401 and 9,173,862. 60 capsules — 30-day supply.

What's inside — 6 evidence-based ingredients

L-DOPA (from Mucuna pruriens seed extract) — 100 mg
Supports retinal signaling through the GPR143 receptor in the retinal pigment epithelium. Involved in both pigment biology and retinal maintenance.

Melatonin — 5 mg
A naturally occurring hormone that regulates circadian rhythm, aligning the formula with the eye's overnight maintenance and renewal cycle.

Lutein (from Tagetes erecta L. flower) — 5 mg
Concentrates in the macula to help filter high-energy blue light and support macular pigment optical density. Included at doses studied in AREDS2 clinical trials.†

Zeaxanthin (from Tagetes erecta L. flower) — 2 mg
Works alongside lutein in the fovea to support central vision and macular pigment. Also studied in AREDS2 clinical trials.†

Vitamin C (as Ascorbic Acid) — 100 mg
An antioxidant that helps support the body's natural defenses against oxidative stress in retinal cells. Included in the AREDS clinical formula.

Vitamin E (as D-Alpha Tocopheryl Acid Succinate) — 35 mg
Supports antioxidant defense in photoreceptor cell membranes and retinal tissue. Part of the AREDS and AREDS2 clinical trial evidence base.

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.